Cancer comorbidity: Implications for drug safety

Katherine Tabor O'Brien*, June M McKoy, Frank Penedo

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer is primarily a disease of aging. This chapter discusses relevant aspect of the physiology of aging, medication use and toxicity, comorbidities, and specific challenges in treating older adults with cancer.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages21-35
Number of pages15
DOIs
StatePublished - Jan 1 2019

Publication series

NameCancer Treatment and Research
Volume171
ISSN (Print)0927-3042

    Fingerprint

Keywords

  • Comorbidities
  • Comprehensive geriatric assessment
  • Drug toxicity
  • Frailty
  • Physiology of aging
  • Polypharmacy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

O'Brien, K. T., McKoy, J. M., & Penedo, F. (2019). Cancer comorbidity: Implications for drug safety. In Cancer Treatment and Research (pp. 21-35). (Cancer Treatment and Research; Vol. 171). Springer International Publishing. https://doi.org/10.1007/978-3-319-43896-2_2